Extremely oblique sclerotomy incision reduces wound leakage in vitrectomy

Article

Extremely oblique sclerotomy incision (OSI) has a self-sealing effect on sclerotomy wound leakages.

Extremely oblique sclerotomy incision (OSI) has a self-sealing effect on sclerotomy wound leakages, says an investigation published in Retina.

The nested case-control study, led by Dr Albert L. Lin, Department of Ophthalmology, Cullen Eye Institute, Houston, Texas, USA, involved 48 patients with wound leaks and 171 control patients without leaks. Patients received either a conventional sclerotomy incision of 45°, changed to 90° midincision, or an OSI at 10°, changed to 30° midincision.

Age, gender, laterality, duration of surgery, preoperative diagnosis, vitrectomy history, sclerotomy incision and primary surgeon were the risk factors investigated.

After using multivariate logistic regression analysis it was discovered that OSI, macular preoperative diagnosis, surgical duration, no previous vitrectomy, and female gender were the protective factors for wound leakage. Using OSI compared to a standard sclerotomy incision reduces the chance of wound leakage.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.